Sign In
Buy SNN
$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
10:00am, Tuesday, 27'th May 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year*
The CARTIHEAL Implant will be featured at the Arthroscopy Association of North America Annual Meeting (AANA 2025) this week
Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland
02:00am, Monday, 05'th May 2025
“CORI on Tour” will highlight the latest advancements in robotics-assisted surgery for hip and knee joint replacement Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today
Smith & Nephew plc (SNN) Q1 2025 Earnings Call Transcript
05:42pm, Friday, 02'nd May 2025
Smith & Nephew plc (NYSE:SNN ) Q1 2025 Results Conference Call April 30, 2025 3:30 AM ET Company Participants Deepak Nath - Chief Executive Officer John Rogers - Chief Financial Officer Conference Cal
Smith & Nephew shares jump 7% on better-than-expected quarterly growth
09:48am, Wednesday, 30'th Apr 2025
Smith & Nephew PLC (LSE:SN) rose as much as 7% in afternoon trading on Wednesday after the medical technology group reported stronger-than-expected revenue growth in the first quarter of 2025. The Lon
Smith & Nephew jumps as hip and knee replacements in demand
03:17am, Wednesday, 30'th Apr 2025
Smith & Nephew PLC (LSE:SN) shares rose over 5% to top the early FTSE 100 leaderboard on Wednesday after the knee and hip replacer maintained its full-year 2025 guidance after seeing growth of 3.1% i
Is Smith & Nephew SNATS (SNN) a Great Value Stock Right Now?
10:45am, Tuesday, 29'th Apr 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
New Strong Buy Stocks for April 29th
07:26am, Tuesday, 29'th Apr 2025
MATX, SNN, ALEX, PCB and LTH have been added to the Zacks Rank #1 (Strong Buy) List on April 29, 2025.
Smith & Nephew: Underappreciated Recovery With Strategic Upside
10:09pm, Saturday, 19'th Apr 2025
Smith & Nephew is undergoing a turnaround under CEO Deepak Nath, focusing on margin expansion and growth through surgical robotics and regenerative technologies. Despite trading at a discount to peers
Trump tariffs: these two European healthcare stocks face the highest US revenue exposure
09:34am, Thursday, 03'rd Apr 2025
Global financial markets are in turmoil this morning after the US President announced sweeping tariffs on several countries in a push to lower the nation's trade deficit. Trump's new tariffs are parti
Smith & Nephew falls after downgrade by leading investment bank
07:41am, Wednesday, 12'th Mar 2025
Shares in Smith & Nephew PLC (LSE:SN) fell 2% after UBS downgraded stock in the med-tech firm to 'neutral' from 'buy' on valuation grounds. The price target remains at £12.50.
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
11:00am, Tuesday, 11'th Mar 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Sur
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
11:00am, Monday, 10'th Mar 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopae
New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty
10:00am, Thursday, 06'th Mar 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian Orthopaedic Association National Joint Replacement Regi
Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research
08:20am, Monday, 03'rd Mar 2025
The global wound care market size was valued at USD 23.13 billion in 2024 and is projected to reach from USD 24.04 billion in 2025 to USD 32.75 billion by 2033, growing at a CAGR of 3.94% during th
